Ethical approval: Not required. The authors would like to thank Dr. buy Sunitinib Ziad Memish, Assistant Deputy Minister of Health for Preventive Medicine MOH, KSA and Dr. Chris Van Beneden, Centers for Disease Control and Prevention, Atlanta, GA, USA, for their valuable advice and support. The authors would also like to thank the WH Administration, Departments of Quality Management, Nursing, Obstetrics/Gynecology, Laboratory, Anesthesia, Emergency, Radiology, Respiratory Therapy, Emergency Medical Services, CSSD, Medical Records, Housekeeping, Engineering and Emergency Medical Services and all of the Women’s Hospital
staff for their continuous cooperation and support in making the control of the GAS outbreak a success. The authors would also like to thank Ms. Rajula Shaheem for her excellent secretarial support. “
“In an increasingly large amount of scientific literature, DA-HAIs are considered the principal threat to patient safety in the ICU and are among the main causes of patient morbidity and mortality [1] and [2]. In industrialized countries, device-associated healthcare-associated infection (DA-HAI) surveillance in the intensive care unit (ICU) plays a substantial role in hospital infection control and quality assurance [3] and was reported by the Centers for Disease Control
and Prevention (CDC) study of the efficacy of nosocomial Regorafenib molecular weight infection control (SENIC) as an efficacious tool to reduce DA-HAIs [4]. The CDC’s previous National Nosocomial Infection Surveillance System (NNIS) and current National Healthcare Safety Network (NHSN) have established standardized criteria for DA-HAI surveillance [5] and [6]. This standardized surveillance method allows for the determination of DA-HAI rates per 1000 device-days, which can be used as benchmarks
among healthcare centers, and provides infection control practitioners (ICPs) with an in-depth look at the institutional problems they are confronted with so they can design an effective strategy to solve them. However, in the context of an expanded framework for DA-HAI control, most of the relevant studies of ICU-acquired infections have been carried out filipin in industrialized countries [7]. In developing countries, in contrast, few published studies have reported DA-HAI rates using standardized definitions [8], [9], [10], [11], [12], [13], [14] and [15]. The International Nosocomial Infection Control Consortium (INICC) was founded in 1998, when selected hospitals from Latin America were invited to participate in the project to measure DA-HAIs using standardized definitions and methodology [16]. Subsequently, other hospitals from different parts of the world joined the INICC. Currently, the INICC comprises a worldwide network of 300 hospitals from 40 countries in Latin America, Asia, Africa and Europe [12]. On a monthly basis, healthcare facilities send data to the INICC, which are then entered into an international database.